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OBJECTIVE — The goals of this study were to examine the inﬂuence of maternal type 1
diabetes during pregnancy on offspring adiposity and glucose tolerance at age 7 years and to
assesswhethermetabolicfactorsatbirth(neonatalleptinandinsulin)predictadverseoutcomes.
RESEARCHDESIGNANDMETHODS — Weexamined100offspringofmotherswith
type 1 diabetes (OT1DM) and 45 offspring of control mothers. Mothers had previously been
recruitedduringpregnancy,and,wherepossible,birthweight,umbilicalcordinsulin,andleptin
were measured. Children were classed as overweight and obese using age-speciﬁc reference
ranges.
RESULTS — OT1DM had similar height (control, 1.25  0. 06 m; OT1DM, 1.24  0.06 m;
P0.81)butwereheavier(control,25.53.8kg;OT1DM,27.15.7kg;P0.048)andhad
an increased BMI (control, 16.4 kg/m
2; OT1DM, 17.4  2.6 kg/m
2, P  0.005). Waist circum-
ference (control, 56.0  3.7 cm; OT1DM, 58  6.8 cm; P  0.02) and sum of skinfolds were
increased (control, 37.5  17.0 mm [n  42]; OT1DM, 46.1  24.2 mm [n  91]; P  0.02),
and there was a marked increase in the prevalence of overweight and obese children (OT1DM,
22% overweight and 12% obese; control, 0% overweight and 7% obese; 
2 P  0.001). Glucose
tolerance was not different compared with that in control subjects. BMI at age 7 years correlated
withcordleptin(OT1DM,r0.25;n61,P0.047),weaklywithadjustedbirthweight(r
0.19;P0.06)andhematocrit(r0.25;n50,P0.07),butnotcordinsulin(OT1DM,r
0.08; P  0.54).
CONCLUSIONS — OT1DM are at increased risk of overweight and obesity in childhood.
This risk appears to relate, in part, to fetal leptin and hematocrit but not insulin.
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T
here is increasing interest in the hy-
pothesis that cardiovascular and
metabolic diseases might be inﬂu-
enced by early life events. A number of
studies have suggested that exposure to
maternal diabetes prior to birth increases
the risk of type 2 diabetes and obesity in
later life (1). Notably, the best evidence
comes from populations at a high under-
lying genetic risk of type 2 diabetes and
obesity (1) where observational studies
and sibling studies suggest that the pres-
ence of maternal diabetes during preg-
nancy substantially increases risk of type
2 diabetes and obesity in childhood and
earlyadultlife.Similarly,exposuretoma-
ternal hyperglycemia increases the pen-
etrance of maturity-onset diabetes of the
young (MODY) (2). Offspring of mothers
with type 1 diabetes (OT1DM) have been
foundtohaveanincreaseinBMIinchild-
hood in some (3) but not all series (4).
Recently, an increase in BMI in OT1DM
has been found in young adults in Den-
mark as well as in increase in the preva-
lence of impaired glucose tolerance (5).
Importantly, presence of raised cord or
amniotic ﬂuid insulin in OT1DM has also
beenfoundtobeassociatedwithlateroff-
spring obesity (6,7,3).
In this study, we examined glucose
tolerance and adiposity at age 7 years in
children of mothers with type 1 diabetes
previously examined in a multicenter
pregnancycohortstudy.Further,weused
theextensivephenotypingofthecohortat
birth to examine which of a number of
changes previously identiﬁed at birth in
this cohort—most notably raised birth
weight, fetal hyperinsulinemia, and fetal
hyperleptinemia (8), but also increased
cord hematocrit (9), C-reactive protein
(CRP) (10), and reduced adiponectin
(11)—might be associated with risk of
offspring obesity.
RESEARCH DESIGN AND
METHODS— Recruitment for the
original Fetal Insulin and Glycaemia
Study (FIGS) began in January 1999 and
ended in May 2001 and took place in
eight hospital-based antenatal centers in
Scotland (8). A total of 250 women with
type 1 diabetes consented to participate
in the study (a 94% participation rate of
those enrolled and planning to deliver in
thecenters),andcordbloodsampleswere
obtained from the umbilical vein after
placental separation at delivery for 200
(80%) women. Of these 200, 140 speci-
mens met restriction criteria (no evidence
ofhemolysisofcord;cordbloodcollected
within 20 min, centrifuged and plasma
frozenwithin60min;antenatalglucocor-
ticoids not administered in the 24 h be-
fore birth; and children delivered before
33 weeks’ gestation) as previously de-
scribed (8).
A convenience sample of control
mothers, who had no history of obstetric
ormetabolicdiseaseandinwhomroutine
screeningforgestationaldiabetesmellitus
(using national guidelines [http://www.
sign.ac.uk/guidelines],SIGN[ScottishIn-
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was negative, was recruited from routine
obstetric follow-up clinics after the 34th
weekofpregnancyinthesamecenters.Of
the 145 control women who gave initial
consent, cord samples were attempted in
75 and obtained in 70. Forty-eight con-
trol collections met the above restriction
criteria.
Data on clinical outcome including
caesarean section, intercurrent medical
conditions, and hypertensive conditions
of pregnancy were obtained by case note
review including maternal smoking his-
tory recorded as current, ex-smoker, or
nonsmoker. Smoking history was not
available in two cases. Gestational ages
were calculated from estimated dates of
delivery from chart review. This date was
derived from dates of last menstrual pe-
riod (LMP), where available, or by ultra-
sound if there was a conﬂict with dates as
assessed by LMP (6 days) or LMP was
unavailable.
Cord blood assays
Plasma insulin, 32-33 split proinsulin,
proinsulin, leptin, IGF-I (8), CRP (10),
andadiponectin(11)wereassayedbyval-
idated methods as previously described.
Maternal A1C was measured centrally by
one laboratory (8).
Examination in childhood
Children were invited to a study exami-
nation by a letter to their parent. Follow-
ing written consent from the parent and
assent from the child, data were obtained
on weight (Marsden MPMS 230 portable
personal scale; Marsden, Henley-on-
Thames, U.K.), height (Marsden H226),
ﬁve-point skinfold measurements (tri-
ceps, biceps, subscapular, suprailiac,
and para-umbilical, Holtain Tanner/
Whitehouse skinfold calipers; Holtain,
Crosswell, U.K.), blood pressure taken
sitting three times after 5 min of rest (us-
ing Rossmax Mandaus  Pro Kit sphyg-
momanometer kit with stethoscope and
young adult cuff 18–27 cm), and waist
measurement using tape measure in cen-
timeters (12). Participants were invited to
have an oral glucose tolerance test 1.75 g
of glucose/kg body wt up to a total of 75 g
of glucose with blood sampling fasting
and at 30 and 120 min and glucose toler-
ance categorized using World Health
Organization (WHO) 1999 criteria. A
total of 45 control offspring and 100
OT1DM were examined, representing
31% of the control subjects and 40% of
OT1DM originally enrolled in the
study. For both control subjects and
OT1DM, those with follow-up at age 7
years had birth weight, maternal age at
delivery, and gestation at delivery simi-
lar to those without follow-up and sim-
ilar duration of diabetes in the OT1DM
(data not shown).
SDscoresforBMI,weight,andheight
were calculated using reference curves
(13) based on population data from the
U.K.in1990.Generaloverweight/obesity
was deﬁned using the International Obe-
sity Taskforce (IOTF) age- and sex-
speciﬁc thresholds for childhood BMI
(14), and central obesity was deﬁned as
an age- and sex-speciﬁc waist circumfer-
ence 90th percentile (15), based on
waist circumference percentile curves de-
rived for British children (12).
Both the original FIGS and the cur-
rent study received ethical approval from
the appropriate research ethics com-
mittees.
Statistical analysis
Data were analyzed using standard soft-
ware (SAS version 9.1, Cary, NC). For
normally distributed variables, data are
reported as means  SD; in several cases
(insulin and leptin), measures were not
normally distributed and unadjusted val-
uesarepresentedasmedian(interquartile
range) and variables were logarithmically
transformed to obtain normal distribu-
tions. For correlation and regression
models, SD scores of birth weight and
body weight at age 7 years are used. In-
tergroup differences were assessed by un-
paired t test or, where further predictor
variables were included, by general linear
models. Spearman correlation coefﬁ-
cients are reported. Stepwise logistic re-
gressionwasperformedusinganofP
0.15 for adding or removing predictors
from the model.
RESULTS— A total of 100 OT1DM
and 45 offspring of control mothers (con-
trol) consented to take part in the study.
Mothers were of similar age and parity
(supplementary Table A1, available at
http://care.diabetesjournals.org/cgi/
content/full/dc09-1766/DC1). OT1DM
were born around 1.5 weeks earlier on
average and more often by caesarean sec-
tion.OT1DMweremarkedlyheavierwith
z scores of birth weight 1.8 SD above the
expected for the background population.
Where available, cord insulin and leptin
were increased in OT1DM (supplemen-
tary Table A1), in keeping with the larger
datasetfromtheoriginalcohort(8),while
differences in hematocrit (9), CRP (10),
and adiponectin previously found in the
larger set (11) were in similar directions,
although not formally signiﬁcant in this
subgroup (supplementary Table A1).
Children were examined at an aver-
age of 7.4 years in both groups (Table 1).
Height was not different between
OT1DMandcontrolsubjectseitherinab-
solute terms or when expressed as an SD
score (Table 1). By contrast, weight,
waist circumference, total sum of skin-
folds, and BMI were signiﬁcantly in-
creasedinOT1DM(by1.6kg,2cm,9.6
mm, and 1.0 kg/m
2, respectively) with
an accompanying signiﬁcant increase in
the SD score for BMI and waist circum-
ference (Table 1). Glucose either fasting
or after glucose load was not increased
in OT1DM, and fasting insulin was not
increased (Table 1). No children ful-
ﬁlled WHO criteria for either impaired
fasting glucose or impaired glucose
tolerance.
Figure 1—Proportion of overweight and obese in OT1DM.
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in BMI, there was a signiﬁcant increase in
children classiﬁed as either obese or over-
weight with 22 (22%) OT1DM over-
weight and 12 (12%) obese compared
withnooverweightchildrenand3(6.7%)
obese in the control group (P  0.001)
(Fig. 1). Central obesity (waist circumfer-
ence 90th percentile) was present in
36% of OT1DM and 9% of control sub-
jects (
2 P  0.001).
Importantly, mothers with diabetes
were heavier at follow-up (mean  SD
maternal BMI: OT1DM, 27.3  5.2
kg/m
2andcontrol,24.84.4kg/m
2;P
0.004)—adifferencethatwasnotapparent
in fathers (OT1DM, 27.5  3.7 kg/m
2;
control, 26.5  2.8; P  0.19). Despite
this, the difference in offspring BMI did
not appear to be explained by differences
in mothers’ weights. Maternal and child
BMI were related in the control group
(r0.34;P0.02)butnotOT1DM(r
0.10; P  0.34). Differences between
OT1DM and control were maintained af-
ter addition of maternal BMI as a predic-
tor term (BMI SD score mean adjusted for
maternal BMI  SEM: OT1DM, 0.67 
0.11 and control, 0.33  0.16; P  0.08)
(child BMI mean adjusted for maternal
BMI  SEM: OT1DM, 17.3  0.24 and
control, 16.4  0.35; P  0.03). Differ-
ences in children’s BMI were more appar-
ent in subgroups of mothers currently
normal weight (child BMI SD score
mean  SEM: OT1DM, 0.63  0.21 and
control 0.14  0.13; P  0.0013) com-
pared with those currently overweight or
obese (child BMI SD score mean  SEM:
OT1DM,0.730.14andcontrol0.52
0.21; P  0.39).
Characteristics at birth of children
OT1DM overweight or obese at age 7
years were examined. Notably, OT1DM
found to be overweight or obese at age 7
years had age at delivery, cord insulin,
CRP, and adiponectin very similar to
those in normal weight OT1DM at age 7
years. Although birth weight and skin-
folds at birth were signiﬁcantly increased
in the OT1DM found to be overweight or
obese at age 7 years compared with con-
trolsubjects,thesemeasuresshowedonly
nonsigniﬁcant increases compared with
those in OT1DM found to be normal
weight at age 7 years (Table 2). OT1DM
who were overweight or obese at age 7
years had signiﬁcantly higher values of
cord leptin at birth and hematocrit com-
pared with those in normal-weight
OT1DM. When analyzed as continuous
variables, there were no signiﬁcant rela-
tionships of BMI, waist circumference, or
sum of skinfolds to measures at birth
(cord insulin, cord leptin, cord CRP, and
birth weight) in the control group. By
contrast, cord leptin was positively asso-
ciated with BMI at age 7 years (r  0.24;
P  0.04) and cord hematocrit with total
skinfolds (r  0.33; P  0.02) and waist
circumference (r  0.28; P  0.049)
(supplementary Table A2).
Instepwisemultivariateanalysis,BMI
centile at age 7 years was related only to
hematocrit (9% of variance P  0.05 in a
model also potentially including birth
weight, cord insulin, leptin, adiponectin,
IGF-I, and maternal and paternal BMI
[n  50]). Inclusion of maternal smoking
history did not inﬂuence the relationship
of fetal hematocrit and BMI at age 7 years
inOT1DM(effectofhematocritP0.03;
effect of maternal smoking category P 
0.31). When hematocrit was excluded,
cord leptin accounted for 4.6% of the
variance of BMI at age 7 years (P  0.11,
n  74).
CONCLUSIONS — Detailed analy-
ses from the Pima Indian population have
demonstrated that fetal exposure to ma-
ternal diabetes increases the risk of obe-
sity and type 2 diabetes for the offspring
in later life (1). While critical in this pop-
ulation,ithasbeenlessclearwhetherpro-
gramming of childhood glucose tolerance
would be observed in populations at less
severe genetic risk of obesity and type 2
diabetes. Further, there are few studies
exploring whether markers at birth might
highlight the mechanisms by which in
utero programming is occurring.
For obesity, our data suggest that the
presenceofmaternaldiabetesmayindeed
program later adiposity in children. It is
notable that while the overall increase in
BMI is modest (1.0 kg/m
2), there is a
changeinthedistributionofweightinthe
population of OT1DM with a marked in-
crease in children in the overweight and
obese categories suggesting a potential
upwardshiftinthedistributionofweight.
It is unclear at this stage whether other
children will be at increased risk of over-
weight in later life or whether risk will be
concentrated in a susceptible subgroup.
Our data are in agreement with the data
from the Pima Indian population (1) and
examination of a mixed population of
OT1DM and with gestational diabetes
(7). Although the data from the Pima In-
dian population are compelling, teasing
apart the relative effects of maternal obe-
sity and hyperglycemia along with poten-
tial genetic and environmental effects is
complex in a population at high underly-
ing genetic risk of obesity and type 2 dia-
betes. There are fewer studies of OT1DM,
Table 1—Anthropometric and biochemical measures in children at follow-up
Control children
Children of mothers with
type 1 diabetes P
N 45 100
Age (years) 7.4  0.36 7.4  0.45 0.81
Height (cm) 124.7  6.0 124.5  6.3 0.81
Height SD score 0.085  1.03 0.06  1.04 0.89
Weight (kg) 25.5  3.8 27.1  5.7 0.047
Weight SD score 0.23  0.92 0.52  1.24 0.12
BMI 16.4  1.6 17.4  2.6 0.005
BMI SD score 0.28  0.78 0.69  1.2 0.02
Skinfold (total in mm) 37.5  17.0 46.1  24.1 0.02
n 91
Waist (cm) 56.0  3.7 58.0  6.8 0.02
Waist SD score 0.35  0.91 0.86  1.63 0.02
Fasting glucose (mmol/l) 4.5  0.4 4.5  0.3 0.99
n 19 53
30-min glucose (mmol/l) 7.5  1.7 7.7  1.62 0.67
n 17 46
120-min glucose (mmol/l) 5.7  0.8 5.1  1.3 0.12
n 12 34
Fasting insulin (pmol/l) 16.9 (12.1–20.2) 17.9 (10.7–27.5) 0.84
n 19 51
Continuous variables are presented as means  SD or medians (25th–75th interquartile range) depending
on distribution and examined using t test or Wilcoxon test, respectively.
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the more isolated effects of maternal hy-
perglycemia in pregnancy. Manderson et
al. (4) in Northern Ireland found no in-
crease in BMI in children born to mothers
with type 1 diabetes aged 8.6 years, al-
though speciﬁc analysis of overweight
andobesewasnotundertakenandtheage
distribution of children was broad (5–11
years). In a small study (15 cases),
Sobngwi et al. (16) did not ﬁnd an in-
crease in adiposity in young adult
OT1DM, whereas Weiss noted an in-
crease of 1.6 kg/m
2 in 71 OT1DM exam-
ined between 5 and 15 years of age (3).
More recently, Clausen et al. (5) reported
an increase in BMI of 1.1 kg/m
2 in
OT1DM at 26.5 years and an increase in
rates of overweight (41%) and obese
(10%) compared with the control popu-
lation (24% overweight and 5% obese)
(17). Taken together, these studies would
suggest that maternal hyperglycemia is
acting to increase the risk of overweight
and obesity in childhood and into adult
life.
One criticism of such studies is
whether the control group is truly repre-
sentativeofthegeneralpopulation.Inour
case, it is notable that there were no chil-
dren in the control group in the over-
weight category. In boys, BMI (mean 
SD) in the control group of the current
study (boys, 16.4  1.8 kg/m
2; girls,
16.4  1.4 kg/m
2; all, 16.4  1.6 kg/m
2)
is slightly higher than that reported in the
Avon Longitudinal Study of Parents and
Children (ALSPAC) at a similar age
(16.22.0kg/m
2atage7.5yearswithno
differences between sexes) (18). Both av-
erage BMI in ALSPAC and rates of obesity
(9.2% in boys and 8.1% in girls) (19) are
similar to those in our control group and
lower than those observed in OT1DM in
our study.
Due to the availability of cord mea-
sures, we are able to go beyond previous
studies. Silverman et al. (6,20) and Weiss
et al. (3) reported that higher amniotic
ﬂuid insulin was associated with in-
creased BMI in childhood. By contrast,
children in our cohort who were over-
weight and obese had cord insulin con-
centrations similar to those in OT1DM
found to be normal weight at follow-up,
although both groups have markedly
raised cord insulin concentrations com-
pared with those in control subjects.
Thereisastrongcorrelationbetweencord
insulin at birth and amniotic ﬂuid insulin
toward the end of pregnancy (21), and
this should not account for the difference
between the studies. Interpretation of the
study of Silverman et al. is made more
complex by the mix of mothers with type
1 and gestational diabetes included. In
our series, leptin rather than insulin acts
as a marker of later adiposity. Leptin is a
robust marker of neonatal fat mass (22),
and indeed there is a trend toward higher
birth weight and skinfolds in offspring
later developing overweight or obesity in
our series. To our knowledge, no other
series has related obesity risks to such
markers in OT1DM at birth. We have de-
scribed a number of hormonal and other
changesatbirthinthiscohortofOT1DM.
Cord insulin, leptin, and birth weight (8)
are markedly raised, hematocrit (9) and
CRP (10) are more modestly increased,
and adiponectin decreased (11). While
several of these changes are intercorre-
lated, insulin and leptin are not particu-
larly strongly related in OT1DM (r 
0.22) (8). Neither leptin nor insulin are
relatedtohematocritatbirth(9).Assuch,
changes in insulin, leptin, and hematocrit
Table 2 —Characteristics at birth of OT1DM obese or overweight in childhood
Control children
Children of mothers with type 1 diabetes P OT1DM obese or
overweight vs. OT1DM
normal weight
Normal weight at age
7 years
Overweight or obese
at age 7 years
N 45 66 34
Gestational age at delivery (weeks  SEM) 39.9  0.3 37.6  0.24* 37.1  0.33* 0.30
Birth weight (kg) 3.44  0.1 3.57  0.08 3.76  0.1* 0.19
Total skinfolds at birth (mm) 11.2  1.4 13.9  0.9 15.3  1.1* 0.34
z score of birth weight 0.23  0.22 1.61  0.19* 2.13  0.26* 0.11
Cord insulin (pmol/l) 27.9 (20.7–37.7) 139.8 (114.8–170.6)* 128.9 (101–167.2)* 0.82
n 16 38 23
Cord leptin (mcg/ml) 8.25 (6.4–10.7) 20.5 (17.2–24.4)* 37.7 (30.1–47.2)* 0.03
n 21 47 28
Cord hematocrit 0.52  0.01 0.52  0.01 0.56  0.01* 0.03
n 18 31 19
Cord adiponectin 21.6  1.5 18.9  1.0 19.7  1.2 0.59
n 18 44 29
Cord CRP 0.17 (0.15–0.19) 0.19 (0.18–0.20) 0.21 (0.19–0.24) 0.42
n 20 45 27
Maternal A1C, weeks 5–12 (%) — 7.6  0.2 8.2  0.4 0.11
n 29 18
Maternal A1C, weeks 16–24 (%) — 6.7  0.14 6.9  0.2 0.43
n 36 22
Maternal A1C, weeks 26–34 (%) — 6.8  0.1 7.1  0.2 0.10
n 46 30
Maternal A1C, weeks 35–40 (%) — 6.5  0.2 6.9  0.2 0.12
n 31 22
Continuous variables are presented as means  SE or geometric means with range  1 SE. *Difference from control P  0.05. Boldface data indicates P  0.05 for
OT1DM obese or overweight different from OT1DM normal weight.
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adverse fetal environment in OT1DM. Of
all of these markers, only leptin and he-
matocrit emerge as markers of later over-
weight and obesity in childhood in our
population, although notably these mea-
sures at birth explain a relatively small
proportion (10%) of the overall vari-
ance of BMI at age 7 years.
Hematocrit has been known for some
time to be increased in offspring of moth-
ers with diabetes (23) and proposed to
increase in response to fetal hypoxia, ad-
verse placental function, or as direct ef-
fects of insulin (23). In our cohort, while
the increase in hematocrit is fairly typical
of other series, there was no convincing
relationship of hematocrit to insulin, sug-
gesting that fetal hyperinsulinemia was
not playing a direct role in stimulating
erythropoiesis (9), although hematocrit
showedamodestrelationshiptomaternal
A1C (r  0.30; P  0.02) (9). Interest-
ingly,thereisabroaderliteraturesuggest-
ing that maternal smoking, a known
determinant of hematocrit, is associated
with an increase in offspring obesity, a
ﬁnding noted in the ALSPAC (19) as well
as other series (24), although the mecha-
nistic basis of this remains unknown. We
have recently shown only subtle struc-
tural changes in the placenta in the same
series. The hypothesis that structural or
functional changes in the placenta under-
pin programming of obesity in the cohort
remains to be tested.
There is keen interest at present into
understanding determinants of fetal and
neonatal fat mass and the extent to which
the fetal environment will increase adult
disease. It is known that leptin acts as a
marker of fetal fat mass (22), and it may
be that increased fetal adiposity rather
than leptin per se is the key intermediary
between the intrauterine environment
andlaterriskofadiposityinoffspring.Al-
ternatively,leptinhasarangeofeffectson
appetite and insulin sensitivity (22), and
it is therefore possible that leptin is pro-
gramming, for example, appetite at a
more fundamental level. At present, there
is not an extensive literature examining
cord leptin as a marker of later obesity.
Ong et al. (25) have reported an inverse
relationship between cord leptin and
weightgainin197healthychildrenatage
2 years; with assessment of adiposity so
early in life, it is difﬁcult to judge the rel-
evance of such ﬁndings to our study.
Maternal hyperglycemia has also
been associated with an increased risk of
later impaired glucose tolerance and type
2 diabetes. Again, the largest follow-up is
fromthePimaIndians(1),butanincrease
in impaired glucose tolerance has also
been reported in OT1DM in early adult-
hood in Paris (16) and an increase in a
composite of type 2 diabetes and pre-
diabetes in the larger Danish series (5).
We found no difference in glucose toler-
ance. This may reﬂect the younger age of
ourcohortandisinkeepingwiththeﬁnd-
ings of Manderson et al. (4) at a similar
age.
In conclusion, we demonstrate that
maternal type 1 diabetes is associated
with an increased risk of overweight and
obesity in childhood. Both cord leptin
and hematocrit emerge as intermediate
markersofthisrisk.Ourdatasuggestthat
obesity may be programmed in utero via
hyperglycemia, and interventions in
pregnancy may be critical to try to
inﬂuence long-term risk of disease in
offspring.
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